- ORCID iD
- 0000-0001-6289-7288
Show
Sort by
-
- Journal Article
- A1
- open access
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis
-
- Journal Article
- A1
- open access
Development of engineered endolysins with in vitro intracellular activity against streptococcal bovine mastitis‐causing pathogens
-
Engineering of bacteriophage-derived endolysins to treat streptococcal mammary gland infections
(2023) -
Endolysin NC5 improves early cloxacillin treatment in a mouse model for bovine Streptococcus uberis mastitis
-
- Journal Article
- A1
- open access
Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis : a proof-of-concept study
-
- Conference Paper
- C3
- open access
Characterization of endolysins PlySs2 & -9 with in vitro lytic activity against bovine mastitis Streptococcus uberis
-
A method for the purification of non-pyrogenic bacteriophage derived endolysins with an in vitro or in vivo application
-
- Journal Article
- A1
- open access
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
-
One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer
-
Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer
-
Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer
-
Immunomodulation by cisplatin chemotherapy in an immunocompetent intraductal model for triple-negative breast cancer
-
- Journal Article
- A1
- open access
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer
-
- Journal Article
- A1
- open access
Enterobactin deficiency in a coliform mastitis isolate decreases its fitness in a murine model : a preliminary host-pathogen interaction study
-
- Journal Article
- A1
- open access
Characterization of the bacteriophage-derived endolysins PlySs2 and PlySs9 with in vitro lytic activity against bovine mastitis streptococcus uberis
-
- Journal Article
- A1
- open access
Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer
-
The PlySs9 endolysin contains unique catalytic domains and is a potential therapeutic against Streptococcus suis
-
Development of the PlyC endolysin as a bovine mastitis therapeutic for lactating dairy cows
-
Comparative immune profiling of an aggressive 4T1-based versus a non-aggressive Py230-based intraductal model for triple-negative breast cancer
-
- Conference Paper
- C3
- open access
The PlySs9 endolysin and its amidase subdomain reveal potential roles in the treatment of Gram-positive bovine mastitis
-
- Journal Article
- A1
- open access
Potential therapeutic application of bacteriophages and phage-derived endolysins as alternative treatment of bovine mastitis
-
Tumor immune profiling and host NF-kappaB activity assessment in a novel Py230-based intraductal model for triple-negative breast cancer